Gut vs Hepatology: Which Should You Submit To?

The 10-point IF gap (25.8 vs 15.8) looks large on paper. It is worth understanding what drives it.

Gut publishes 172 citable items per year. Hepatology publishes 320. When total citations are divided by a smaller denominator, the IF rises. Gut is genuinely more selective (fewer papers, each cited more heavily) but the quality difference is not as dramatic as "25.8 vs 15.8" implies.

Gut's five-year IF (25.3) is nearly identical to its two-year IF (25.8), which means citation velocity is sustained. Hepatology's five-year IF (14.5) is slightly below its two-year IF (15.8), suggesting a modest front-loading of citations. Both patterns are normal for high-tier clinical journals.

Within the gastroenterology rankings, Gut sits at 4th and Hepatology at 7th of 147 journals. Both are in the top 5% of their field. For context, the journals ranked above Gut are Nature Reviews Gastroenterology & Hepatology (IF 51.0), Lancet Gastroenterology & Hepatology (IF 38.6), and Journal of Hepatology (IF 33.0), all of which are either review journals or Lancet-family titles with different editorial models.

Gut publishes research across the entire gastrointestinal tract: esophagus, stomach, small bowel, colon, and pancreas. The journal also covers hepatology as part of its GI scope. This breadth means Gut accepts diverse research types, colorectal cancer, inflammatory bowel disease, pancreatic disease, liver disease, GI motility, and microbiome studies. The journal emphasizes work with implications beyond a single organ system.

Hepatology is exclusively focused on liver disease: viral hepatitis, liver fibrosis and cirrhosis, hepatocellular carcinoma, autoimmune liver disease, metabolic dysfunction-associated steatotic liver disease (MASLD), and liver transplantation. The journal does not publish GI research outside the liver.

In practice: if your research is about colon cancer, inflammatory bowel disease, or pancreatic disease, Gut is the clear choice, Hepatology does not publish it. If your research is liver-specific, both journals will consider it, but the strategic question is whether your audience is GI-wide or liver-specific.

Where Gut is strongest

Gut dominates in several areas where Hepatology cannot compete:

• Inflammatory bowel disease, Gut is the top destination for Crohn's and UC research outside of specialized IBD journals
• Colorectal cancer screening and prevention, Gut has published landmark screening trials that shaped clinical guidelines
• GI microbiome, The journal's scope naturally encompasses host-microbe interactions across the entire tract
• Cross-organ GI physiology, Research connecting gut-liver axis, gut-brain axis, or pan-GI mechanisms fits Gut's breadth

Where Hepatology is strongest

Hepatology has specific advantages for liver work:

• MASLD/NASH, Hepatology has published the defining studies in metabolic liver disease, including the nomenclature consensus itself
• Viral hepatitis treatment, HBV and HCV cure-era papers cluster heavily in Hepatology because the AASLD community drives clinical practice
• Liver transplantation, Transplant outcomes, allocation policy, and post-transplant management papers find their natural home here
• Liver fibrosis staging and biomarkers, The journal has strong editorial interest in non-invasive fibrosis assessment

Gut editors are highly selective. The journal receives thousands of submissions and desk-rejects the majority within 2-3 weeks. To pass desk review at Gut, your work must be high-impact, novel, and of broad GI significance. Incremental studies, small cohorts, or narrow findings are unlikely to reach peer review. However, papers that pass desk review at Gut are taken seriously, the open peer review model (BMJ standard) means reviewers know their names are attached to their comments.

Hepatology editors are somewhat more permissive. The journal will send well-executed research to peer review even if it is somewhat incremental, as long as it advances understanding of liver disease. The bar for peer review is lower than at Gut, which means more papers get reviewed and more have a path to acceptance. The single-blind review model is traditional.

In practical terms: if you are unsure whether your liver research meets the impact bar, Hepatology is more likely to give you peer review. But if your work is truly high-impact liver research with implications beyond the liver, Gut is the prestige target.

Submit to Gut when:

• your research is non-liver GI (colorectal, pancreatic, esophageal, small bowel), Hepatology is not an option
• your liver research has broad implications for GI science or general medicine
• your work connects multiple organ systems (gut-liver axis, microbiome effects on liver disease)
• you want maximum IF and are confident the work passes Gut's desk triage
• you are building a career profile that spans gastroenterology, not just hepatology

Submit to Hepatology when:

• your research is focused on liver disease mechanisms, treatment, or outcomes
• the hepatology community (AASLD, EASL) is your primary readership
• your work is strong but may not meet Gut's desk triage bar for broad GI impact
• you are building a career specifically in hepatology and want community recognition
• you have a clinical trial or large cohort study in liver disease that needs the AASLD audience

Submit to Journal of Hepatology (IF 33.0) when:

• your liver research is at the highest impact tier, above both Gut and Hepatology for liver-specific work
• J Hepatol (EASL's journal, IF 33.0, ranked 3rd of 147) is actually the highest-ranked liver-specific journal and deserves consideration alongside Gut for top-tier liver submissions

For a gastroenterologist building an academic career: Gut publications are the gold standard. Gut's readership spans the entire GI field, and a Gut paper on any GI topic carries weight on every promotion committee.

For a hepatologist building an academic career: both journals matter, but for different reasons. Hepatology publications build reputation within the AASLD community, the people who attend your conference talks, review your grants, and invite you to write guidelines. Gut publications signal broader impact. Most successful hepatologists publish in both.

For a non-hepatologist with liver-relevant findings (surgeon, radiologist, pathologist): Gut is usually the better target because it reaches the broader clinical audience who might apply your findings.

For early-career researchers: Hepatology's higher acceptance rate and more permissive desk review make it a safer first-choice for strong-but-not-blockbuster liver research. Getting a Hepatology paper early builds community credibility faster than a Gut desk rejection followed by a lower-tier publication.

If Gut rejects your liver research at the desk, Hepatology is an excellent second choice, in fact, it may be the right choice from the start. Hepatology editors read independently and do not penalize papers rejected elsewhere. The feedback from Gut peer review (if you reached that stage) can strengthen your submission.

If you are aiming higher: Journal of Hepatology (IF 33.0) and Lancet Gastroenterology & Hepatology (IF 38.6) sit above both for liver work. For non-liver GI, Lancet Gastroenterology & Hepatology and Nature Reviews Gastroenterology & Hepatology (IF 51.0) are the tiers above Gut.

Both journals allow subscription publication at no cost. If OA is mandated by your funder, check your institution's agreements with BMJ (Gut) or Wolters Kluwer (Hepatology) before comparing sticker prices.

Within hepatology, the Gut vs Hepatology question looks different than it does from outside. Many hepatologists view Hepatology (published by AASLD) as their community's journal. AASLD meetings, guidelines, and professional networks are centered around Hepatology. A paper in Hepatology reaches the hepatology community more directly than a paper in Gut, which reaches a broader GI audience.

For a hepatologist building a career: Hepatology publications build reputation within your professional community. Gut publications signal broader impact beyond hepatology. Both matter, but for different reasons.